ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.040
-0.010 (-0.95%)
At close: Nov 20, 2026, 4:00 PM EST
1.045
+0.005 (0.51%)
After-hours: Nov 20, 2026, 7:52 PM EST
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $146.98 million as of November 20, 2026. It is the 21,988th most valuable company in the world and the 3,694th biggest in the United States. Its market cap has decreased by 31.27% in one year.
Market Cap
146.98M
Enterprise Value
46.58M
1-Year Change
-31.27%
Global Rank
Country Rank
#3,694 United States
Category
ChartMarket Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has increased from $94.98M to $146.98M, an increase of 54.75%. That is a compound annual growth rate of 3.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 146.98M | -30.93% |
| Dec 31, 2025 | 212.80M | -22.19% |
| Dec 31, 2024 | 273.49M | 70.20% |
| Dec 29, 2023 | 160.69M | -39.20% |
| Dec 30, 2022 | 264.31M | -53.63% |
| Dec 31, 2021 | 569.95M | 170.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 155.24M |
| InflaRx | 153.26M |
| Palisade Bio | 150.58M |
| Eledon Pharmaceuticals | 150.48M |
| Atrium Therapeutics | 149.27M |
| Veraxa Biotech AG | 147.06M |
| BridgeBio Oncology Therapeutics | 145.25M |
| Sutro Biopharma | 142.77M |